Loading...
Docoh

Glaxosmithkline (GSK)

News

From Benzinga Pro
GlaxoSmithKline: Dividend Insights
16 May 22
Dividends
Wednesday marks the last chance for investors to receive the next dividend payout from GlaxoSmithKline (NYSE:GSK).
HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty
12 May 22
Analyst Color, Biotech, News, Health Care, Price Target, Reiteration, Analyst Ratings, Movers, Trading Ideas, General
GSK's Panadol and Sensodyne-maker Haleon in Talks to Hire Banks
3 May 22
News
-Sky News https://news.sky.com/story/gsks-45bn-panadol-and-sensodyne-maker-haleon-in-talks-to-hire-banks-12604875
GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine
27 Apr 22
Biotech, Earnings, Large Cap, News, Guidance, Health Care, Movers, Trading Ideas, General
GlaxoSmithKline Earlier Reported Q1 EPS $0.88 Beats $0.76 Estimate, Sales $13.13B Beat $11.70B Estimate
27 Apr 22
Earnings, News
GlaxoSmithKline (NYSE:GSK) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.76 by 15.79 percent. This is a 39.68 percent increase over earnings of $0.63 per share from the
Recap: GlaxoSmithKline Q1 Earnings
27 Apr 22
Earnings, News
GlaxoSmithKline (NYSE:GSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
27 Apr 22
Biotech, Earnings, Large Cap, M&A, News, Penny Stocks, Health Care, Financing, Offerings, Small Cap, FDA, Movers, Trading Ideas, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For April 27, 2022
27 Apr 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
GlaxoSmithKline's Earnings Outlook
26 Apr 22
Earnings
GlaxoSmithKline (NYSE:GSK) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that GlaxoSmithKline will report an earnings per share (EPS) of $0.76.
Ameresco Reports Completion Of Solar Panel Project With GlaxoSmithKline At GSK Consumer Healthcare's Oak Hill, New York Site, No Terms Disclosed
26 Apr 22
News
The comprehensive solar panel project is designed to generate electricity equivalent to more than 70% of the Oak Hill site’s annual usage and reduce its carbon footprint by 60% FRAMINGHAM, Mass. & OAK HILL,
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
22 Apr 22
Government, News, Health Care, General
The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data
21 Apr 22
Biotech, News, Penny Stocks, Health Care, Small Cap, FDA, Management, Movers, Trading Ideas, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance
21 Apr 22
Earnings, News, Guidance, Health Care, General
UPDATE: CureVac, GlaxoSmithKline Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study (Body Of This Headline Contains Contents Of Press Release)
21 Apr 22
Biotech, News, FDA, General
- Vaccine candidate combining Beta- and Delta-specific mRNAs shows strong protection and immune responses during preclinical challenge study - Demonstrated neutralizing capacity against the Omicron variant in vaccinated
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
18 Apr 22
Biotech, Government, News, Health Care, Top Stories, General
In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a positive test,
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
17 Apr 22
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, General
Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting season.
Sierra Oncology Stock Is Soaring: Here's Why
13 Apr 22
M&A, Small Cap, Movers, Trading Ideas
Sierra Oncology Inc (NASDAQ: SRRA) shares are trading significantly higher Wednesday after the company announced it will be acquired by GlaxoSmithKline PLC (NYSE: GSK) for $55 per share in cash, representing an a
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
13 Apr 22
Biotech, M&A, News, Penny Stocks, Health Care, Small Cap, FDA, Movers, Trading Ideas, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal
GlaxoSmithKline Scoops Up Rare Cancer-Focused Sierra Oncology In $1.9B Cash Deal
13 Apr 22
Biotech, M&A, News, Health Care, Small Cap, Movers, Trading Ideas, General
GSK Reached Agreement to Acquire Sierra Oncology For $55/Share
13 Apr 22
M&A, News, Small Cap
GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology, a California-based, late-stage biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer, for $55 pe

Press releases

From Benzinga Pro
SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA
5 May 22
Press Releases
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Sierra Oncology, Inc (NASDAQGM:SRRA) to GlaxoSmithKline plc
Voltaren Teams Up with Actress Jennie Garth to Support Caregivers Nationwide
4 May 22
Entertainment, Press Releases, General
In partnership with the actress and caregiver, the brand kicks off CareWalks, a pledge to caregivers across the country that offers resources and encourages movement through a new video series, a charitable donation and
SIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRA
2 May 22
Press Releases
Kuznicki Law PLLC is investigating the proposed sale of Sierra Oncology, Inc (NASDAQGM:SRRA) to GlaxoSmithKline plc (NYSE:GSK). Under the terms of the proposed transaction, shareholders of Sierra will receive only
MOBI Makes Their Post-Pandemic NYC Debut
2 May 22
Entertainment, Press Releases, General
MOBItalks is back and ready to empower attendees with conversation around alternative wellness, understanding sex therapy, and black queer joy with industry leaders and community activists. NEW YORK, May 2, 2022
SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA
25 Apr 22
Press Releases
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Sierra Oncology, Inc (NASDAQGM:SRRA) to GlaxoSmithKline plc
Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing
14 Apr 22
Small Cap, Opinion, Press Releases
PALM BEACH, Fla., April 14, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - CAR-T therapy is a sort of treatment in which a patient's T cells which is a type of immune system cell, are genetically
SHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc.
13 Apr 22
Press Releases
NEW YORK, April 13, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sierra Oncology, Inc. ("Sierra" or the
SIERRA ONCOLOGY ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of SRRA and Encourages Investors to Contact the Firm
13 Apr 22
News, Legal, Press Releases
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Sierra
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
13 Apr 22
Press Releases
Sierra Oncology's differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia Momelotinib complements GSK's existing expertise in haematology, with
New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+
6 Apr 22
Press Releases
Analysis of data collected between March 2020–February 2021 from nearly 2 million Americans indicates patients diagnosed with COVID-19 may be more likely to develop shingles in the six months following
Neuraminidase Inhibitors Drug Market- Overview by Manufactures, Business Analysis, Opportunity, Industry Growth, and Forecast to 2028
29 Mar 22
New York, United States, Tue, 29 Mar 2022 06:47:48 / Comserve Inc. / -- Top Key Players; F. Hoffmann La Roche- Roche Holding AG (SWX: RO), GlaxoSmithKline plc (NYSE:GSK), Gilead Sciences Inc. (NASDAQ:GILD), Daiichi
Xerostomia Therapeutics Market Business Growth, Demand, Trends, Key Players, And Forecast To 2029
28 Mar 22
New York, United States, Mon, 28 Mar 2022 13:27:22 / Comserve Inc. / -- Top Key Players; 3M (NYSE:MMM), Apotex Inc., Church & Dwight Co. Inc., Colgate-Palmolive Co. (NYSE:CL), Cumberland Pharmaceuticals Inc.
BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
28 Mar 22
Earnings, Press Releases
JERUSALEM, March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and
Diverticulitis Drugs Market High Demand, Size, Share, Processing Industry, Insight Growth, And Forecast By 2029
28 Mar 22
New York, United States, Mon, 28 Mar 2022 09:46:43 / Comserve Inc. / -- Top Key Players; Emmaus Life Sciences, Inc. (OTC:EMMA), Synergy Pharma, Abbott Laboratories (NYSE:ABT), GlaxoSmithKline plc (NYSE:GSK), Ardelyx,
Antiretroviral Drugs Market Expected to Grow at a CAGR of 6% during 2020-2028
28 Mar 22
New York, United States, Mon, 28 Mar 2022 05:53:21 / Comserve Inc. / -- The antiretroviral drugs market is anticipated to record a CAGR of around 6% over the forecast period, i.e., 2020-2028. Research Nester has
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
25 Mar 22
Health Care, Press Releases
SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (NYSE:GSK) and Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that the US Food and Drug Administration has amended the Emergency Use
Sterile Injectable Drugs Market Size, Share, Growth and Trends, Forecast to 2029
9 Mar 22
New York, United States, Thu, 10 Mar 2022 03:06:08 / Comserve Inc. / -- The global sterile injectable drugs market is expected to witness growth at a considerable CAGR during the forecast period i.e., 2021-2029.Research
Alacer Corp. Launches New Eco-Conscious Toothpaste Brand Natean®
7 Mar 22
Press Releases
New brand debuts with four clean ingredient toothpastes available exclusively at Walmart Alacer Corp. today announced the launch of Natean®, a new eco-conscious oral healthcare brand providing products to